Asthma treatment under the microscope: how trimbow works in daily life

NCT ID NCT04902573

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This completed study followed 147 adults with moderate to severe asthma who were prescribed Trimbow, a triple-therapy inhaler, as part of their routine care. Researchers collected data on patient characteristics, treatment patterns, asthma control, quality of life, and lung function over time. The goal was to understand how this medication performs in real-world settings, outside of strict clinical trials.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Trimbow (beclometasone/formoterol/glycopyrronium)

What this could lead to

If successful, this study could provide real-world evidence on how Trimbow works in everyday asthma care, potentially guiding better treatment decisions.

What could go wrong

This is an observational study, not a controlled trial, so results may be influenced by factors like patient selection or routine care variations. It cannot prove cause and effect.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ASTHMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

asthma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • The Haven Surgery, The Haven, Burnhope,

    Durham, County Durham, DH7 0BD, United Kingdom